3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Lymphoma, Large B-Cell, Diffuse
36
Multiple Myeloma
33
Burkitt Lymphoma
32
Lymphoma
30
Leukemia, Myeloid, Acute
29
Lymphoma, Non-Hodgkin
28
Recurrence
26
Breast Neoplasms
26
Lymphoma, B-Cell
23
Neoplasms
22
Myelodysplastic Syndromes
20
Lymphoma, Follicular
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Hodgkin Disease
17
Triple Negative Breast Neoplasms
16
Leukemia
16
Ovarian Neoplasms
15
Hematologic Neoplasms
15
Melanoma
14
Neuroblastoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12
Lymphoma, Mantle-Cell
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Pancreatic Neoplasms
11
Leukemia, Biphenotypic, Acute
10
Sarcoma
9
Neoplasm Metastasis
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myelomonocytic, Chronic
9
Interventions
Magnetic Resonance Spectroscopy
5
lutetium Lu 177 dotatate
4
Specimen Handling
4
Radiosurgery
3
gallium Ga 68 dotatate
2
Ga(III)-DOTATOC
2
Bevacizumab
2
regorafenib
1
pembrolizumab
1
olaparib
1
neratinib
1
capivasertib
1
cabozantinib
1
brigatinib
1
abemaciclib
1
X-Rays
1
Watchful Waiting
1
Tablets
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Protons
1
Proton Therapy
1
Photons
1
Observation
1
ONC206
1
Nivolumab
1
Mental Status and Dementia Tests
1
Lysine
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningioma
×
Cyclophosphamide
×
90 days
×
Clear all
No trials found.